Join Now

Category Archives: COVID-19 Updates

RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

By Denise Bell | Published September 18, 2020

Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]

Also posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Co-Diagnostic Enters into Agreement with Arches Research to Expand COVID-19 Testing

By Denise Bell | Published September 11, 2020

Co-Diagnostics, a Salt Lake City company that was out of the gate early with a molecular COVID-19 test, announced this week that it has entered into an agreement with another Salt Lake City based company, Arches Research, a CLIA laboratory and subsidiary of PolarityTE to expand Arches’ COVID-19 testing services using Co-Diagnostics’ Logix Smart™ COVID-19 […]

| Leave a comment

Drug Companies Pledge to Stand with Vaccine Science

By Denise Bell | Published September 11, 2020

The CEOs of nine pharmaceutical manufacturers working on COVID-19 vaccines – AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi – signed a pledge Tuesday to “uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.” In the pledge, the […]

| Leave a comment

Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

By admin | Published September 11, 2020

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]

Also posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

Utah Leads Together Accountability Framework

By admin | Published September 11, 2020

This Utah Leads Together Accountability Framework presents Utah’s strategic, data-driven, and concentrated effort to protect the lives and livelihoods of all Utahns. The framework includes a clear mission, two major goals, six supporting objectives, and a variety of lead measures and strategies. A scorecard of measurable targets motivates progress. Together with a refined accountability structure, […]

| Leave a comment

HHS Move Upends FDA Role in Laboratory-Developed Test Regulation

By admin | Published August 28, 2020

By Adam Bonislawski for GenomeWeb NEW YORK – In a surprise move, the US Department of Health and Human Services said on Wednesday that it had determined the Food and Drug Administration would not require premarket review of laboratory-developed tests without notice-and-comment rulemaking. The announcement, which took many in the lab industry aback, appeared to […]

Also posted in HHS/FDA & Other Regulatory | | Leave a comment

COVID-19 Grant Relief Program Updates as of 8/12/2020 9:20 am

By admin | Published August 13, 2020

Shop In Utah: $35M (+ $10M added from ComRent) Opened Monday, July 27 – closed August 7, 2020, at 1:30 p.m. Shop in Utah number of applications received: 872 Shop in Utah total award amount requested: $42,344,434 Shop in Utah number of awards: 653 Shop in Utah total award amount: $26,790,444 Average award amount: $41,023 […]

Also posted in Funding | | Leave a comment

House Bill Introduced to Provide COVID-19 Economic Relief to Startups

By Denise Bell | Published August 7, 2020

Bipartisan legislation to help entrepreneurs and startups navigate the economic perils of COVID-19, has been introduced in the U.S. House of Representatives. The bill, the IGNITE American Innovation Act (H.R. 7917), introduced by Reps. Dean Phillips (D-MN) and Jackie Walorski (R-IN), will allow many small companies that have not benefited from CARES Act relief to […]

Also posted in COVID-19 Legislation, Policy News | | Leave a comment

At White House Roundtable, CSL Behring CEO Paul Perreault Urges Plasma Donations to Fight COVID-19

By Denise Bell | Published July 31, 2020

At a July 30 White House Roundtable, plasma industry leader and CSL Behring (CSL) CEO Paul Perreault, urged people who have recovered from COVID-19 to consider donating plasma to help develop a potential treatment for people with serious complications from COVID-19. Representing the plasma industry, Perreault pointed to the unprecedented CoVIg-19 Plasma Alliance – an […]

Also posted in BioUtah News, Federal News | | Leave a comment

Senate Republicans Release HEALS Act – COVID-19 Stimulus Package

By Denise Bell | Published July 31, 2020

Earlier this week, Senate Majority Leader Mitch McConnell released the Republican version of a fourth COVID-19 package (or as some say, a second round of a CARES Act stimulus bill). The bill, titled the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act is actually a collection of bills. Highlights include another round of $1200 […]

Also posted in COVID-19 Legislation, Federal News, Policy News | | Leave a comment

President Trump Signs Drug Pricing Executive Orders, Touts “Most Favored Nation” Pricing

By Denise Bell | Published July 31, 2020

Last Friday, President Trump signed four executive orders aimed at lowering drug prices, including an order that would set up a “most favored nation” (MFN) pricing model for Medicare Part B drugs, effectively imposing foreign price controls on critical medicines for seniors. The goal, Trump said, is to “end global freeloading on the backs of […]

Also posted in Federal News, Policy News | | Leave a comment

Pfizer and BionTech Announce Agreement with U.S. Government for Up to 600 million doses of COVID-19 Vaccine Candidate

By Denise Bell | Published July 24, 2020

On July 22, Pfizer and BioNTech announced the execution of an agreement with the HHS and DOD to meet the U.S. government’s Operation Warp Speed program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021. Under the agreement, the U.S. government will receive 100 million doses of BNT162, the COVID-19 […]

Also posted in Federal News | | Leave a comment

A Special Thanks To Our Elite Members